Cargando…
Demethoxycurcumin analogue DMC-BH exhibits potent anticancer effects on orthotopic glioblastomas
Demethoxycurcumin (DMC) has anti-glioma effects in vitro and in subcutaneous xenotransplanted tumors. Our previous study confirmed that the molecule also has mild anti-glioma effects on orthotopic glioblastomas in vivo. In this study, we found that DMC-BH, a DMC analogue, exhibited more potent in vi...
Autores principales: | Shi, Lei, Sun, Guan, Zhang, Yong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7762498/ https://www.ncbi.nlm.nih.gov/pubmed/33221748 http://dx.doi.org/10.18632/aging.103981 |
Ejemplares similares
-
Demethoxycurcumin analogue DMC-BH inhibits orthotopic growth of glioma stem cells by targeting JNK/ERK signaling
por: Shi, Lei, et al.
Publicado: (2020) -
Promising antitumor effects of the curcumin analog DMC-BH on colorectal cancer cells
por: Liu, Gang, et al.
Publicado: (2023) -
MicroRNA 145 enhances chemosensitivity of glioblastoma stem cells to demethoxycurcumin
por: Qian, Chunfa, et al.
Publicado: (2019) -
Demethoxycurcumin represses cervical cancer growth through PPARγ-regulated proliferation and apoptosis: DMC suppresses cervical cancer tumorigenesis
por: Tang, Jing, et al.
Publicado: (2023) -
Curcumin analogue BDDD-721 exhibits more potent anticancer effects than curcumin on medulloblastoma by targeting Shh/Gli1 signaling pathway
por: Gong, Weiyi, et al.
Publicado: (2022)